Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie
Modern treatment programs for adults with acute lymphoblastic leukemia
β Scribed by Farhad Ravandi; Stefan Faderl; Partow Kebriaei; Hagop Kantarjian
- Book ID
- 107540178
- Publisher
- Current Science Inc.
- Year
- 2007
- Tongue
- English
- Weight
- 157 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1558-8211
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent treatment strategies in adult ALL mainly include (1) intensification of induction and consolidation chemotherapy, (2) molecular targeting, particularly in Ph/bcr abl pos-ALL, (3) antibody therapy and (4) extension of stem cell transplantation (SCT). New diagnostic tools are used to refine def
At the present time, it is possible to achieve up to a 95% complete remission in childhood acute lymphoblastic leukemia, using the combination of vincristine and prednisone. Nevertheless, it has not been possible to reproduce these results in the adult. For this reason, a third drug, in this case a